FIELD: biotechnology.
SUBSTANCE: present inventions relates, in particular, to the myovirus bacteriophage Clo-PEP-1, selected from nature and having a gene represented by the nucleotide sequence of SEQ. ID. NO: 1 (registration number: KCTC 12664 BP). Invention also relates to a method for preventing or treating infections caused by cells Clostridium perfringens, using a composition containing said bacteriophage as an active ingredient.
EFFECT: inventions allows using the claimed bacteriophage, which is capable of specifically killing cells Clostridium perfringens, and can be used in the medical industry.
5 cl, 2 dwg, 3 tbl, 8 ex
